Technical Analysis for MBRX - Moleculin Biotech, Inc.

Grade Last Price % Change Price Change
F 3.6 -5.01% -0.19
MBRX closed down 5.01 percent on Monday, April 12, 2021, on 16 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical MBRX trend table...

Date Alert Name Type % Chg
MACD Bearish Signal Line Cross Bearish 0.00%
Oversold Stochastic Weakness 0.00%
Narrow Range Bar Range Contraction -5.01%
Inside Day Range Contraction -5.01%
Oversold Stochastic Weakness -5.01%
Hammer Candlestick Bullish -6.74%
Narrow Range Bar Range Contraction -6.74%
Stochastic Reached Oversold Weakness -6.74%
Oversold Stochastic Weakness -6.74%
Calm After Storm Range Contraction -6.74%
Older End-of-Day Signals for MBRX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakdown about 16 hours ago
Down 5% about 17 hours ago
Lower Bollinger Band Support about 17 hours ago
Down 3% about 17 hours ago
Down 2 % about 17 hours ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Moleculin Biotech, Inc., a preclinical and clinical-stage pharmaceutical company, focuses on the development of anti-cancer drug candidates. Its lead drug candidate is liposomal Annamycin, an anthracycline intended for the treatment of relapsed or refractory acute myeloid leukemia. The company also develops other drugs, including WP1066 Portfolio, a portfolio of small molecules targeting the modulation of transcription factors involved in cancer; and WP1122 Portfolio, a suite of molecules targeting the metabolic processes involved in cancer and glioblastoma. Moleculin Biotech, Inc. was founded in 2015 and is headquartered in Houston, Texas.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Pharmaceutical Oncology Chemotherapy Acute Myeloid Leukemia Blastoma Antineoplastic Drugs Stage Pharmaceutical Glioblastoma Transcription Transcription Factors Transcription Factor Refractory Acute Myeloid Leukemia

Is MBRX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 11.82
52 Week Low 3.1374
Average Volume 3,578,137
200-Day Moving Average 5.07
50-Day Moving Average 4.40
20-Day Moving Average 4.00
10-Day Moving Average 3.90
Average True Range 0.29
ADX 16.02
+DI 22.20
-DI 29.98
Chandelier Exit (Long, 3 ATRs ) 3.91
Chandelier Exit (Short, 3 ATRs ) 4.43
Upper Bollinger Band 4.43
Lower Bollinger Band 3.57
Percent B (%b) 0.04
BandWidth 21.54
MACD Line -0.17
MACD Signal Line -0.17
MACD Histogram -0.0009
Fundamentals Value
Market Cap 224.87 Million
Num Shares 62.5 Million
EPS -0.32
Price-to-Earnings (P/E) Ratio -11.25
Price-to-Sales 0.00
Price-to-Book 3.34
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.92
Resistance 3 (R3) 3.94 3.86 3.86
Resistance 2 (R2) 3.86 3.78 3.85 3.84
Resistance 1 (R1) 3.73 3.73 3.69 3.71 3.83
Pivot Point 3.65 3.65 3.63 3.64 3.65
Support 1 (S1) 3.52 3.57 3.48 3.50 3.37
Support 2 (S2) 3.44 3.52 3.43 3.36
Support 3 (S3) 3.31 3.44 3.34
Support 4 (S4) 3.29